Ninth Circuit Weighs Revival of Antitrust Suit Against Qualcomm Over Patent Licensing Practices

In a legal battle with potential ramifications on the tech industry, an attorney representing a proposed class of cellphone buyers has requested that the U.S. Court of Appeals for the Ninth Circuit revive antitrust claims against Qualcomm. The argument is centered on the allegation that Qualcomm leveraged “weak patents” to cement its market position, entering…

Read More

Utah Doll Maker Granted Path to Sue Chinese Firms for Copyright Violation in Federal Court

In a recent legal development, the Tenth Circuit has allowed a Utah company, known for producing realistic human-sized dolls, to pursue a copyright infringement suit against two Chinese entities within a Utah federal court. The decision hinges on a clause indicating that these overseas companies consented to legal jurisdiction in locations where Amazon, a global…

Read More

Human Rights Watch Report Highlights Flaws in Investigation of Salvadoran Advisor’s Death

Human Rights Watch (HRW) has published a report scrutinizing the medical treatment and subsequent investigation into the death of Alejandro Muyshondt, former security advisor to the Salvadoran government. Muyshondt died under controversial circumstances this February while in custody following charges related to drug trafficking levied against him in August of the previous year. The report…

Read More

The New York Times Takes Legal Action Against Perplexity AI Over Copyright Dispute

The New York Times has initiated a legal challenge against Perplexity AI Inc., as reported by Law360. The core of the allegation is that the AI company is improperly utilizing copyrighted content from the newspaper. The Times has issued a cease-and-desist letter, asserting that Perplexity’s actions violate intellectual property laws. In response, Perplexity AI maintains…

Read More

Challenges Persist for Women Lawyers in Business Development: Gender Barriers in the Legal Field

The legal profession, traditionally dominated by men, continues to present obstacles for women, particularly when it comes to business development—a crucial component of career advancement known colloquially as “making it rain.” Despite the progress in gender diversity in some areas within the field, data paints a less encouraging picture regarding women’s ability to generate substantial…

Read More

VoIP-Pal.com Shifts Legal Strategy to Target Telecom Giants in Antitrust Battles

Patent-holding company VoIP-Pal.com has announced a strategic shift in its litigation focus. The company revealed it will now target the major telecommunications carriers in antitrust lawsuits, moving away from pursuing patent infringement cases. This decision follows the recent dismissal of their patent suits against Verizon and T-Mobile. This transition marks VoIP-Pal.com’s intent to address broader…

Read More

Federal Circuit Upholds Decision Blocking Ballot Device Patent, Affecting Smartmatic Litigation

The Federal Circuit recently dismissed an attempt to reinstate specific language in a patent related to a “ballot marking device” designed for disabled voters. This patent had previously been asserted against the vote-counting business Smartmatic USA Corp., but the court’s decision maintains its non-active status, impacting any potential claims against Smartmatic. For further details on…

Read More

U.S. Court Dismisses $9 Billion Case Against Iraqi Kurdistan Regional Government for Lack of Clarity in Claims

In a recent legal development, U.S. District Judge Randolph D. Moss has dismissed an amended civil complaint against the Iraqi Kurdistan Regional Government that sought damages of $9 billion. The dismissal was based on the complaint’s failure to meet the legal requirement of providing a “short and concise statement of the allegations,” a deficiency highlighted…

Read More

GSK Sues Moderna Over Alleged Patent Infringement on mRNA Technologies in Vaccines

GlaxoSmithKline (GSK) has initiated legal action against Moderna, claiming that the mRNA technology employed in Moderna’s COVID-19 vaccine, as well as their respiratory syncytial virus (RSV) vaccine, infringes on patents owned by GSK. The lawsuits have been filed in Delaware, centering around the assertion that the foundational mRNA technology utilized in these vaccines was initially…

Read More

Democratizing Legal Information: Free Law Project’s Mission for Transparent Access

As the legal landscape continues to evolve, tools that promote access and transparency are becoming increasingly crucial. In this context, a recent discussion with Michael Lissner, co-founder and executive director of Free Law Project (FLP), offers valuable insights into one such effort aimed at democratizing legal information. Since its founding in 2010, FLP has harnessed…

Read More

UnitedLex Faces Leadership Scrutiny Following CEO’s Abrupt Departure Amid Personal Allegations

The abrupt departure of UnitedLex CEO James Schellhase has raised eyebrows within the legal industry, with his exit coming just after he completed one year in the role. The company announced Schellhase’s departure quietly, leaving many to speculate on the reasons behind it, especially since Schellhase had recently participated in an interview on the LawNext…

Read More

Delaware Judge Dismisses Lenovo-InterDigital Litigation, Clearing Path for New Patent Licensing Agreement

In a significant development in the tech and legal spheres, a Delaware federal judge has dismissed the long-standing antitrust and patent litigation between Lenovo and InterDigital. This resolution follows InterDigital’s announcement that both companies have agreed to terminate their claims. The settlement centers around a patent licensing agreement and a binding arbitration pact, moving both…

Read More

Novartis to Appeal FDA Ruling on Generic Entresto, Aims to Protect Market Share

Swiss pharmaceutical giant Novartis announced plans to appeal a recent decision that disrupted its efforts to challenge the U.S. Food and Drug Administration’s authorization of a generic version of Entresto, a leading heart failure medication. This legal development signifies a critical juncture for Novartis as it seeks to safeguard its interests in a highly competitive…

Read More